These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 9759593)

  • 21. Circulating D dimer in inflammatory bowel disease.
    Biancone L; Scopinaro F; Maletta M; Monteleone G; Luzza F; Banci M; Mercantini P; Renda T; Pallone F
    Ital J Gastroenterol; 1994 Apr; 26(3):116-20. PubMed ID: 8061337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
    Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
    Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural anticoagulant protein levels in Turkish patients with inflammatory bowel disease.
    Cakal B; Gokmen A; Yalinkilic M; Cakal E; Ayaz S; Nadir I; Ozin Y; Dagli U; Ulker A
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):118-21. PubMed ID: 20040858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
    Nos P; Argüello L; Hoyos M; Ramírez JJ; Hinojosa J; Molés JR; García A; Berenguer M; Berenguer J
    Rev Esp Enferm Dig; 1996 Jul; 88(7):470-4. PubMed ID: 8924324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease.
    Hocke M; Richter L; Bosseckert H; Eitner K
    Hepatogastroenterology; 1999; 46(28):2333-7. PubMed ID: 10521992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases.
    Jung YS; Park JJ; Kim SW; Hong SP; Kim TI; Kim WH; Cheon JH
    Dig Liver Dis; 2012 Nov; 44(11):897-903. PubMed ID: 22721842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remission and exacerbation.
    Naftali T; Novick D; Gabay G; Rubinstein M; Novis B
    Isr Med Assoc J; 2007 Jul; 9(7):504-8. PubMed ID: 17710779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High plasma osteopontin levels in patients with inflammatory bowel disease.
    Mishima R; Takeshima F; Sawai T; Ohba K; Ohnita K; Isomoto H; Omagari K; Mizuta Y; Ozono Y; Kohno S
    J Clin Gastroenterol; 2007 Feb; 41(2):167-72. PubMed ID: 17245215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil-elastase in chronic inflammatory bowel disease: a marker of disease activity?
    Gouni-Berthold I; Baumeister B; Wegel E; Berthold HK; Vetter H; Schmidt C
    Hepatogastroenterology; 1999; 46(28):2315-20. PubMed ID: 10521989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
    Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
    Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events.
    Papa A; Danese S; Piccirillo N; Toriani-Terenzi C; Bartolozzi F; Piscaglia AC; Grillo A; Leone G; Gentiloni-Silveri N; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(49):132-5. PubMed ID: 12630008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defense mechanisms in inflammatory bowel disease.
    Hyphantis TN; Triantafillidis JK; Pappa S; Mantas C; Kaltsouda A; Cherakakis P; Alamanos Y; Manousos ON; Mavreas VG
    J Gastroenterol; 2005 Jan; 40(1):24-30. PubMed ID: 15692786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum gastrin levels in patients with inflammatory bowel disease.
    Triantafillidis JK; Tzourmakliotis D; Peros G; Merikas E; Barbatzas C; Cheracakis P; Gikas A; Konstandellou E
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cccxv-cccxvii. PubMed ID: 15244213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
    Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
    Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
    Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The disease activity of ulcerative colitis and Crohn's disease.
    Talstad I; Gjone E
    Scand J Gastroenterol; 1976; 11(4):403-8. PubMed ID: 935802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
    Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
    Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.